In addition, intensive research focused on biological targets which could stimulate GLP-1 release in the gut or pancreas, including GPR120, SSTR5, GPR40, TGR-5 and GPR119
According to the Saxenda Summary of Product Characteristics, treatment should be discontinued if less than 5% weight loss is achieved after 12 weeks on the maintenance dose of 3.0 mg daily Blood pressure and heart rate : Saxenda can increase heart rate, so cardiovascular parameters should be monitored regularly Blood glucose levels : Particularly important for patients with type 2 diabetes or prediabetes, as weight loss and GLP-1 agonist effects can improve glycaemic control Lipid profile and other metabolic markers : To assess improvement in cardiovascular risk factors Mental health and wellbeing : Weight loss can affect mood, and any concerns about depression or suicidal thoughts should be reported immediately Managing common gastrointestinal side effects involves eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and allowing time for your body to adjust to each dose increase
In general, the usual dose is one tablet per day, taken with food
Why did you include botanicals in your ultimate multivitamin+
doi: 10.1038/s41591-024-02996-7 Rubino DM, Greenway FL, Khalid U, et al
[1] [2] In 2024, Wegovy also received FDA approval to reduce cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight
